SCHEMBL20715259

SCHEMBL20715259

c1ccc(-c2nc(-c3ccccc3)c3c(n2)oc2ccc(-c4cc(-n5c6ccccc6c6ccccc65)cc(-n5c6ccccc6c6cc(-c7ccc8oc9ccccc9c8c7)ccc65)c4)cc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.33
SMN1; SMN2 Q16637 5/20 0.33
LMNA P02545 1/20 0.33
NPY5R Q15761 1/20 0.32
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
WHR1 P49842 1/20 0.31
ALDH1A1 P00352 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK1 P06493 1/20 0.31
CCNB1 P14635 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
GSK3B P49841 1/20 0.31
CDK5 Q00535 1/20 0.31
CDK5R1 Q15078 1/20 0.31
MEN1 O00255 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20714947 0.94 SMN1; SMN2 (0.36) CHEK2SMN1; SMN2LMNANPY5RPLA2G2A
SCHEMBL20030036 0.93 ATM (0.37) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL24388302 0.91 L3MBTL1 (0.37) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL20029876 0.91 ATM (0.38) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL20029928 0.91 ATM (0.38) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL24388314 0.90 L3MBTL1 (0.36) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL20029870 0.90 SMN1; SMN2 (0.36) CHEK2SMN1; SMN2LMNAPLA2G2APLA2G4A
SCHEMBL20024196 0.89 TBK1 (0.34) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL20024779 0.89 SMN1; SMN2 (0.33) SMN1; SMN2LMNANPY5RPLA2G2APLA2G4A
SCHEMBL25147296 0.89 SMN1; SMN2 (0.37) CHEK2SMN1; SMN2LMNANPY5RALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2019-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS BRD3, BRPF3, DDT CHEK2 1190/4885SMN1; SMN2 4384/4885LMNA 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.